Evidence map›Paper›PMID 41227161›Full record

ReviewJournal of clinical medicine2025

Therapy with Immune Checkpoint Inhibitors for Solid Tumors in Patients with Preexisting Systemic Autoimmune Diseases.

Sara Elena Campos Ramírez, Pablo Gómez Mugarza, Paula Gomila Pons, Carmen Blanco Abad, María Pilar Felices Lobera, Sofía Elena Ruffini Egea, Pilar Rivero Sobreviela, Luis Gallart Caballero, Paula Morillas Martínez, Ana María Comín Orce

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sara Elena Campos RamírezMedical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain.ORCID 0009-0005-5966-6792
Pablo Gómez MugarzaMedical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain.ORCID 0009-0006-6856-7013
Paula Gomila PonsMedical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain.
Carmen Blanco AbadMedical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain.
María Pilar Felices LoberaMedical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain.
Sofía Elena Ruffini EgeaMedical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain.
Pilar Rivero SobrevielaMedical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain.
Luis Gallart CaballeroMedical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain.
Paula Morillas MartínezMedical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain.
Ana María Comín OrceMedical Oncology, University Hospital Miguel Servet, 50009 Zaragoza, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cutaneous carcinomaefficacyflareimmune checkpoint inhibitorslung cancermelanomarenal cancersafetysolid tumorssystemic immune diseases

Identifiers

PMID41227161
PMCPMC12608399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.